OBJECTIVES: To describe the frequency of adverse reactions (ARs) after transfusion on both per transfused patient and per transfused unit bases. METHODS: We performed a retrospective analysis of data available from records of 6 hospitals on the total number of transfusions and documented ARs between January 2008 and December 2009 for RBCs, fresh-frozen plasma (FFP), and platelet concentrates (PCs). RESULTS: The incidence of ARs to RBCs, FFP, and PCs per transfused unit was 0.6%, 1.3%, and 3.8%, respectively. The incidence of ARs to RBCs, FFP, and PCs per patient was 2.6%, 4.3%, and 13.2%, respectively-almost 3-fold higher. Most RBC-ARs were febrile nonhemolytic transfusion reactions and allergic reactions, whereas most FFP-ARs and PC-ARs were allergic reactions. CONCLUSIONS: The incidence of ARs per transfused patient may reflect better the potential risk of transfusion with blood components, taking into account the characteristics of the transfused patient.
OBJECTIVES: To describe the frequency of adverse reactions (ARs) after transfusion on both per transfused patient and per transfused unit bases. METHODS: We performed a retrospective analysis of data available from records of 6 hospitals on the total number of transfusions and documented ARs between January 2008 and December 2009 for RBCs, fresh-frozen plasma (FFP), and platelet concentrates (PCs). RESULTS: The incidence of ARs to RBCs, FFP, and PCs per transfused unit was 0.6%, 1.3%, and 3.8%, respectively. The incidence of ARs to RBCs, FFP, and PCs per patient was 2.6%, 4.3%, and 13.2%, respectively-almost 3-fold higher. Most RBC-ARs were febrile nonhemolytic transfusion reactions and allergic reactions, whereas most FFP-ARs and PC-ARs were allergic reactions. CONCLUSIONS: The incidence of ARs per transfused patient may reflect better the potential risk of transfusion with blood components, taking into account the characteristics of the transfused patient.
Entities:
Keywords:
Adverse reactions; Hemovigilance; Per transfused patient basis; Transfusion practices
Authors: Sanjida J Mowla; Ian T Kracalik; Mathew R P Sapiano; Lynne O'Hearn; Chester Andrzejewski; Sridhar V Basavaraju Journal: Transfus Med Rev Date: 2021-04-02
Authors: Jonas Hannestad; Katie Koborsi; Vicki Klutzaritz; Whitney Chao; Rebecca Ray; Antonio Páez; Sam Jackson; Scott Lohr; Jeffrey L Cummings; Gary Kay; Karoly Nikolich; Steven Braithwaite Journal: Alzheimers Dement (N Y) Date: 2020-12-16
Authors: Kunal J Ghataliya; Jigar D Kapadia; Mira K Desai; K M Mehariya; G H Rathod; Nidhi Bhatnagar; M D Gajjar Journal: Asian J Transfus Sci Date: 2017 Jul-Dec
Authors: Giovanni Di Minno; Carlo Federico Perno; Andreas Tiede; David Navarro; Mariana Canaro; Lutz Güertler; James W Ironside Journal: Blood Rev Date: 2015-07-20 Impact factor: 8.250